KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020)

Ginkgo Bioworks Holdings' Notes Payables history spans 1 years, with the latest figure at $300000.0 for Q4 2020.

  • For Q4 2020, Notes Payables changed N/A year-over-year to $300000.0; the TTM value through Dec 2020 reached $300000.0, changed N/A, while the annual FY2020 figure was $300000.0, N/A changed from the prior year.
  • Notes Payables reached $300000.0 in Q4 2020 per DNA's latest filing.
  • In the past five years, Notes Payables ranged from a high of $300000.0 in Q4 2020 to a low of $300000.0 in Q4 2020.